Highline Wealth Partners’s Exact Sciences EXAS Stock Holding History

Highline Wealth Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$203	–	1318
2025 Q4	$203	Hold	2	–	–	﹤0.01%	1049
2025 Q3	$109	Hold	2	–	–	﹤0.01%	1069
2025 Q2	$106	Hold	2	–	–	﹤0.01%	881
2025 Q1	$87	Buy	+2	New	+$101	﹤0.01%	1003

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Highline Wealth Partners's EXAS Position: Q1 2026 in Review

Highline Wealth Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2 shares — an estimated $203 sold.

Highline Wealth Partners first reported a position in EXAS in Q1 2025 and held it in 4 quarters. The position peaked at $203 in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Highline Wealth Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Highline Wealth Partners sold 2 Exact Sciences shares in Q1 2026, an estimated $203.
Highline Wealth Partners first reported a position in Exact Sciences in Q1 2025 and held it in 4 quarters.
Highline Wealth Partners's Exact Sciences position peaked at $203 in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Highline Wealth Partners's 13F filing for Q1 2026, filed 6 Apr 2026.